BOLT - Bolt Biotherapeutics, Inc.
5.39
0.400 7.421%
Share volume: 77,171
Last Updated: 04-22-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.18%
PREVIOUS CLOSE
CHG
CHG%
$4.99
0.40
0.08%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 03-24-2025 | 05-12-2025 | 11-12-2025 | 03-12-2026 | |
| Total revenue | 0.000 | 1.222 M | 2.169 M | 2.500 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 1.222 M | 2.169 M | 2.500 M | |
| 77.50% | 15.26% | ||||
| Operating expenses | 15.669 M | 13.337 M | 9.872 M | 8.105 M | |
| Selling general and admin | 3.947 M | 3.825 M | 3.337 M | 3.117 M | |
| Research and development | 11.722 M | 9.512 M | 6.535 M | 4.988 M | |
| Total expenses | 16.916 M | 13.337 M | 9.872 M | 9.585 M | |
| -21.16% | -25.98% | -2.91% | |||
| Operating income | -16.916 M | -12.115 M | -7.703 M | -7.085 M | |
| Ebit | -16.916 M | -12.093 M | -7.621 M | -6.998 M | |
| Pretax income | -15.936 M | -11.040 M | -7.144 M | -6.631 M | |
| -30.72% | -35.29% | -7.18% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -15.936 M | -11.040 M | -7.144 M | -6.631 M | |
| 30.72% | 35.29% | 7.18% |